160 related articles for article (PubMed ID: 16650873)
21. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
Armstrong MB; Bian X; Liu Y; Subramanian C; Ratanaproeksa AB; Shao F; Yu VC; Kwok RP; Opipari AW; Castle VP
Neoplasia; 2006 Nov; 8(11):967-77. PubMed ID: 17132229
[TBL] [Abstract][Full Text] [Related]
22. [Effects of extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activation on proliferation and cell cycle associated genes in human colon cancer cells].
Wang X; Lu R; Fang JY
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(14):982-6. PubMed ID: 17650425
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of gastric surface mucous cells (GSM06) induced by air-liquid interface is regulated partly through mitogen-activated protein kinase pathway.
Yokoyama F; Sakata Y; Ootani A; Fujise T; Kakimoto T; Amemori S; Shiraishi R; Kuroki T; Tsunada S; Iwakiri R; Fujimoto K
J Gastroenterol Hepatol; 2007 Dec; 22(12):2310-5. PubMed ID: 18031396
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
25. Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
Liu D; Hu S; Hou P; Jiang D; Condouris S; Xing M
Clin Cancer Res; 2007 Feb; 13(4):1341-9. PubMed ID: 17317846
[TBL] [Abstract][Full Text] [Related]
26. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
Matsumoto K; Okano J; Nagahara T; Murawaki Y
Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
[TBL] [Abstract][Full Text] [Related]
27. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
[TBL] [Abstract][Full Text] [Related]
28. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of the MAPK/ERK pathway increases sensitivity to 2-chloro-2'-deoxyadenosine (CdA) in the B-cell leukemia cell line EHEB.
Smal C; Lisart S; Maerevoet M; Ferrant A; Bontemps F; Van Den Neste E
Biochem Pharmacol; 2007 Feb; 73(3):351-8. PubMed ID: 17137556
[TBL] [Abstract][Full Text] [Related]
30. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
[TBL] [Abstract][Full Text] [Related]
31. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
Lee M
Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
[TBL] [Abstract][Full Text] [Related]
32. Ascorbic acid 6-palmitate suppresses gap-junctional intercellular communication through phosphorylation of connexin 43 via activation of the MEK-ERK pathway.
Lee KM; Kwon JY; Lee KW; Lee HJ
Mutat Res; 2009 Jan; 660(1-2):51-6. PubMed ID: 19026667
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor-kappaB p65 inhibits mitogen-activated protein kinase signaling pathway in radioresistant breast cancer cells.
Ahmed KM; Dong S; Fan M; Li JJ
Mol Cancer Res; 2006 Dec; 4(12):945-55. PubMed ID: 17189385
[TBL] [Abstract][Full Text] [Related]
34. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway.
Chen L; Liu L; Yin J; Luo Y; Huang S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1284-95. PubMed ID: 19038359
[TBL] [Abstract][Full Text] [Related]
35. Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy.
Friday BB; Adjei AA
Clin Cancer Res; 2008 Jan; 14(2):342-6. PubMed ID: 18223206
[TBL] [Abstract][Full Text] [Related]
36. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
37. Selective downregulation of EGF receptor and downstream MAPK pathway in human cancer cell lines by active components partially purified from the seeds of Livistona chinensis R. Brown.
Huang WC; Hsu RM; Chi LM; Leu YL; Chang YS; Yu JS
Cancer Lett; 2007 Apr; 248(1):137-46. PubMed ID: 16919867
[TBL] [Abstract][Full Text] [Related]
38. Overactivation of the MEK/ERK pathway in liver tumor cells confers resistance to TGF-{beta}-induced cell death through impairing up-regulation of the NADPH oxidase NOX4.
Caja L; Sancho P; Bertran E; Iglesias-Serret D; Gil J; Fabregat I
Cancer Res; 2009 Oct; 69(19):7595-602. PubMed ID: 19773433
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status.
Wang Z; Li Y; Liu ET; Yu Q
Biochem Biophys Res Commun; 2004 Sep; 322(2):609-13. PubMed ID: 15325273
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the MEK/MAPK signal transduction pathway strongly impairs the growth of Flt3-ITD cells.
Takahashi S
Am J Hematol; 2006 Feb; 81(2):154-5. PubMed ID: 16432846
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
